Rakshit Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 4.21 Cr
as on 17-11-2024
- Company Age 19 Year, 27 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 76.17 Cr
as on 17-11-2024
- Satisfied Charges ₹ 34.90 Cr
as on 17-11-2024
- Revenue 9.48%
(FY 2023)
- Profit -61.03%
(FY 2023)
- Ebitda -38.46%
(FY 2023)
- Net Worth 5.99%
(FY 2023)
- Total Assets -7.18%
(FY 2023)
About Rakshit Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.21 Cr.
The company currently has active open charges totaling ₹76.17 Cr. The company has closed loans amounting to ₹34.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjaneya Chandana, Aruna Chandana, Palem Srinivas, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239TG2005PLC048151
- Company No.
048151
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Rakshit Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palem Srinivas  | Managing Director | 07-Mar-2009 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anjaneya Chandana | Director | 23-Nov-2005 | Current |
| Aruna Chandana | Director | 23-Nov-2005 | Current |
| Veera Veerni | Director | 17-Feb-2020 | Current |
| Bhavani Alla | Director | 17-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Rakshit Pharmaceuticals.
Rakshit Pharmaceuticals Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.48% increase. The company also saw a substantial fall in profitability, with a 61.03% decrease in profit. The company's net worth moved up by a moderate rise of 5.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rakshit Pharmaceuticals?
In 2023, Rakshit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Azico Biophore India Private LimitedActive 16 years 1 monthAnjaneya Chandana, Aruna Chandana and 1 more are mutual person
Rakshit Drugs Private LimitedActive 24 years 8 monthsAnjaneya Chandana, Aruna Chandana and 1 more are mutual person
- Sri Bhavana Fabtech Private LimitedActive 14 years 4 months
Anjaneya Chandana and Aruna Chandana are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Dec 2015 | ₹76.17 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 14 Aug 2013 | ₹1.00 M | Satisfied |
Icici Bank Limited Creation Date: 25 Aug 2011 | ₹16.50 Cr | Satisfied |
How Many Employees Work at Rakshit Pharmaceuticals?
Rakshit Pharmaceuticals has a workforce of 61 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rakshit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rakshit Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
